Table 2.
Frequency of diabetic retinopathy (DR) and its pathological features in eyes with and without high myopia.
Absence of high myopia (n, %) | High myopia (n, %) | p value | |
---|---|---|---|
DR | 664 (38.7) | 24 (23.5) | 0.002 |
NPDR | 606 (35.3) | 23 (22.5) | 0.005 |
PDRa | 58 (3.4) | 1 (1.0) | 0.25 |
MA and spot haemorrhage | |||
None | 674 (39.3) | 53 (52.0) | 0.038 |
Mild | 909 (53.0) | 42 (41.2) | |
Severe | 132 (7.7) | 7 (6.9) | |
Hard exudates | |||
None | 1343 (78.3) | 90 (88.2) | 0.017 |
Presence | 372 (21.7) | 12 (11.8) | |
Cotton wool spot | |||
None | 1479 (86.2) | 93 (91.2) | 0.16 |
Presence | 236 (13.8) | 9 (8.8) | |
IRMAa | |||
None | 1643 (95.8) | 102 (100.0) | 0.031 |
Presence | 72 (4.2) | 0 (0.0) | |
VBa | |||
None | 1692 (98.7) | 102 (100.0) | 0.66 |
Presence | 23 (1.3) | 0 (0.0) | |
DME | 215 (12.5) | 10 (9.8) | 0.42 |
Non-CSME | 95 (5.5) | 5 (4.9) | 0.68 |
CSME | 120 (7.0) | 5 (4.9) |
NPDR: non-proliferative diabetic retinopathy; PDR: proliferative DR; MA: microaneurysm; IRMA: intraretinal microvascular abnormality; VB: venous beading; DME: diabetic macular edema; CSME: clinically significant macular edema.
Calculated by Fisher’s exact test, while others calculated by chi-square test.